We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
1901
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $265K | ﹤0.01% |
11,520
-612
| -5% | -$14.3K |
|
1902
Atlanticus Holdings
ATLC
$1.45B
| $263K | ﹤0.01% |
7,486
+267
| +4% | +$10.7K |
|
1903
Ichor Holdings
ICHR
$2.43B
| $263K | ﹤0.01% |
10,131
+507
| +5% | +$14.7K |
|
1904
Shenandoah Telecom
SHEN
$737M
| $262K | ﹤0.01% |
11,794
+2,378
| +25% | +$53.7K |
|
1905
Avista
AVA
$3.2B
| $259K | ﹤0.01% |
5,951
-2,930
| -33% | -$126K |
|
|
THR
1906
DELISTED
Thermon Group Holdings
THR
| $259K | ﹤0.01% |
+18,443
| New | +$285K |
|
|
CMLS
1907
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $259K | ﹤0.01% |
+33,524
| New | +$393K |
|
1908
IMAX
IMAX
$2.81B
| $258K | ﹤0.01% |
+15,274
| New | +$248K |
|
1909
OneSpan
OSPN
$603M
| $258K | ﹤0.01% |
+21,643
| New | +$285K |
|
|
ISEE
1910
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $258K | ﹤0.01% |
26,821
-599
| -2% | -$7.52K |
|
1911
Digi International
DGII
$3.14B
| $257K | ﹤0.01% |
10,620
+1
| +0% | +$22 |
|
|
LAND
1912
Gladstone Land Corp
LAND
$351M
| $257K | ﹤0.01% |
11,582
+4,901
| +73% | +$148K |
|
|
LTC
1913
LTC Properties
LTC
$2.12B
| $257K | ﹤0.01% |
6,691
+138
| +2% | +$5.1K |
|
1914
Park Aerospace
PKE
$801M
| $256K | ﹤0.01% |
+20,070
| New | +$246K |
|
1915
Agilysys
AGYS
$3.02B
| $255K | ﹤0.01% |
5,393
-10,914
| -67% | -$425K |
|
1916
Celldex Therapeutics
CLDX
$3.37B
| $255K | ﹤0.01% |
9,460
| – | – |
|
1917
Universal Corp
UVV
$1.18B
| $255K | ﹤0.01% |
4,211
-456
| -10% | -$27.2K |
|
1918
UWM Holdings
UWMC
$478M
| $255K | ﹤0.01% |
71,979
-782,514
| -92% | -$3M |
|
1919
Allient
ALNT
$1.92B
| $253K | ﹤0.01% |
11,088
-8,782
| -44% | -$216K |
|
|
STR
1920
DELISTED
Sitio Royalties
STR
| $253K | ﹤0.01% |
10,917
-31,242
| -74% | -$865K |
|
1921
Stock Yards Bancorp
SYBT
$2.58B
| $253K | ﹤0.01% |
4,232
-1,768
| -29% | -$98.7K |
|
1922
BancFirst
BANF
$3.77B
| $251K | ﹤0.01% |
+2,621
| New | +$229K |
|
1923
Quanterix
QTRX
$114M
| $251K | ﹤0.01% |
15,473
-20,957
| -58% | -$431K |
|
|
PTVE
1924
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $251K | ﹤0.01% |
25,215
+3,156
| +14% | +$31.8K |
|
|
ATRI
1925
DELISTED
Atrion Corp
ATRI
| $251K | ﹤0.01% |
+399
| New | +$261K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.